@article{605f2d0345f649e9b7d50e5182ca797c,
title = "Can Oritavancin Be Used for Treatment and/or Suppressive Antimicrobial Therapy of Bone and Joint Infections Caused by Vancomycin-resistant Enterococcus faecium ?",
keywords = "Recurrence, Humans, Middle Aged, Male, Treatment Outcome, Arthritis, Infectious/drug therapy, Enterococcus faecium/drug effects, Osteomyelitis/drug therapy, Lipoglycopeptides/therapeutic use, Female, Retrospective Studies, Aged, Gram-Positive Bacterial Infections/drug therapy, Anti-Bacterial Agents/therapeutic use, Vancomycin/analogs \& derivatives, Vancomycin-Resistant Enterococci/drug effects",
author = "Martin Krsak and Taylor Morrisette and Laura Damioli and Brandon Flues and Liu, \{Eugene W.\} and Zhou, \{Anna Y.\} and Msdi, \{Abdulwhab Shremo\} and Caleb McLeod and Saagar Akundi and Mark Redell and Molina, \{Kyle C.\}",
note = "Copyright {\textcopyright} 2025 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Association of Bone and Joint Surgeons.",
year = "2025",
month = jul,
day = "1",
doi = "10.1097/CORR.0000000000003449",
language = "English",
volume = "483",
pages = "1225--1233",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
number = "7",
}